Table I.
Neoplasm | EZH2 | HDAC1 | HDAC2 |
---|---|---|---|
PTCL | 53/82 | 50/82 | 47/82 |
PTCL-NOS | 29/43 | 24/43 | 25/43 |
AICL | 6/10 | 5/10 | 6/10 |
NK/TCL | 7/14 | 8/14 | 8/14 |
ALCL | 11/15 | 13/15 | 8/15 |
EZH2, enhancer of zeste homolog 2; HDAC, histone deacetylase; PTCL, peripheral T cell lymphoma; PTCL-NOS, PTCL not otherwise specified; AICL, angioimmunoblastic T-cell lymphoma; ALCL; anaplastic large cell lymphoma; NK/TCL, natural killer/T-cell.